FB
AZN icon

Fulton Bank’s AstraZeneca AZN Stock Holding History

Fulton Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
8,294
+999
+14% +$188K 0.05% 250
2026
Q1 		$1.44M Sell
7,295
-416
-5% -$80.2K 0.05% 250
2025
Q4 		$1.42M Sell
7,711
-170
-2% -$29.8K 0.05% 247
2025
Q3 		$1.21M Sell
7,881
-140
-2% -$21.2K 0.04% 258
2025
Q2 		$1.12M Buy
8,021
+395
+5% +$55.4K 0.04% 266
2025
Q1 		$1.12M Buy
7,626
+657
+9% +$95.1K 0.05% 250
2024
Q4 		$913K Buy
6,969
+2,304
+49% +$323K 0.04% 292
2024
Q3 		$727K Buy
4,665
+106
+2% +$17.1K 0.03% 333
2024
Q2 		$711K Buy
4,559
+349
+8% +$52.5K 0.03% 323
2024
Q1 		$570K Sell
4,210
-334
-7% -$44.2K 0.02% 365
2023
Q4 		$612K Sell
4,544
-13
-0.3% -$1.69K 0.03% 338
2023
Q3 		$617K Buy
4,557
+2,452
+116% +$335K 0.03% 318
2023
Q2 		$301K Buy
2,105
+578
+38% +$85K 0.01% 447
2023
Q1 		$212K Buy
+1,527
New +$205K 0.01% 517
2022
Q3 		– Sell
-2,008
Closed -$265K – 483
2022
Q2 		$265K Sell
2,008
-351
-15% -$46.1K 0.01% 411
2022
Q1 		$313K Sell
2,359
-74
-3% -$8.87K 0.01% 404
2021
Q4 		$283K Sell
2,433
-247
-9% -$29.1K 0.01% 450
2021
Q3 		$322K Buy
+2,680
New +$312K 0.02% 407
2019
Q1 		– Sell
-11,877
Closed -$889K – 421
2018
Q4 		$889K Sell
11,877
-4,701
-28% -$367K 0.07% 187
2018
Q3 		$1.31M Sell
16,578
-10,375
-38% -$785K 0.09% 174
2018
Q2 		$1.89M Sell
26,953
-9,097
-25% -$654K 0.13% 132
2018
Q1 		$2.52M Sell
36,050
-3,783
-9% -$262K 0.18% 101
2017
Q4 		$2.76M Buy
39,833
+18,375
+86% +$1.24M 0.2% 93
2017
Q3 		$1.45M Buy
21,458
+3,299
+18% +$208K 0.11% 138
2017
Q2 		$1.24M Sell
18,159
-543
-3% -$35.5K 0.1% 147
2017
Q1 		$1.16M Buy
18,702
+5,760
+45% +$335K 0.1% 150
2016
Q4 		$707K Sell
12,942
-512
-4% -$29.1K 0.06% 183
2016
Q3 		$884K Buy
+13,454
New +$879K 0.08% 165
2015
Q1 		– Sell
-5,594
Closed -$394K – 385
2014
Q4 		$394K Sell
5,594
-590
-10% -$42.2K 0.04% 235
2014
Q3 		$442K Sell
6,184
-264
-4% -$19.3K 0.05% 217
2014
Q2 		$479K Sell
6,448
-47,973
-88% -$3.47M 0.05% 213
2014
Q1 		$3.53M Sell
54,421
-2,385
-4% -$154K 0.41% 51
2013
Q4 		$3.37M Sell
56,806
-24,592
-30% -$1.34M 0.4% 53
2013
Q3 		$4.23M Buy
81,398
+7
+0% +$352 0.5% 43
2013
Q2 		$3.85M Buy
+81,391
New +$4.14M 0.48% 47

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Fulton Bank's AZN Position: Q2 2026 in Review

Fulton Bank increased its AstraZeneca (AZN) stake by 14% in Q2 2026, buying an estimated $188K and bringing the position to 8,294 shares worth $1.57M. The position accounts for 0.05% of the portfolio, ranked #250.

Fulton Bank first reported a position in AZN in Q2 2013 and has held it in 35 quarters since. The position peaked at $4.23M in Q3 2013. 233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Fulton Bank held 8,294 shares of AstraZeneca worth $1.57M as of Q2 2026.
  • Fulton Bank bought 999 AstraZeneca shares in Q2 2026, an estimated $188K.
  • AstraZeneca made up 0.05% of Fulton Bank's portfolio in Q2 2026, its #250 holding.
  • Fulton Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 35 quarters since.
  • Fulton Bank's AstraZeneca position peaked at $4.23M in Q3 2013.
  • 233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.